Federal contractors / LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award

75N91018F00070

HHSN261201500003I; HHSN26100070; 400.020.0070.0001; NCI-DCEG; APPROPRIATED; AUTOMATED EVALUATION OF BIOMARKER-STAINED SLIDES; 09/24/2018-09/23/2023

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNIH NCI
NAICS561210 — Facilities Support Services
PSCM1HA — OPERATION OF GOVERNMENT-OWNED CONTRACTOR-OPERATED (GOCO) R&D FACILITIES
Parent award / vehicleHHSN261201500003I
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$1.3M
Current contract value$1.3M
Potential contract value / ceiling$1.3M
Start dateSep 24, 2018
Current end dateSep 23, 2024
Potential end dateSep 23, 2024
Latest award activityMay 11, 2023
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
May 11, 2023P00004$25.6KHHSN261201500003I; HHSN26100070; 400.020.0070.0001; NCI-DCEG; APPROPRIATED; AUTOMATED EVALUATION OF BIOMARKER-STAINED SLIDES; 09/24/2018-09/23/2023
Oct 14, 2021P00003$0HHSN261201500003I; HHSN26100070; 400.020.0070.0001; NCI-DCEG; APPROPRIATED; AUTOMATED EVALUATION OF BIOMARKER-STAINED SLIDES; 09/24/2018-09/23/2023
Nov 9, 2020P00002$434.0KHHSN261201500003I; HHSN26100070; 400.020.0070.0001; NCI-DCEG; APPROPRIATED; AUTOMATED EVALUATION OF BIOMARKER-STAINED SLIDES; 09/24/2018-09/23/2023
Aug 5, 2019P00001$344.8KHHSN261201500003I; HHSN26100070; 400.020.0070.0001; NCI-DCEG; APPROPRIATED; AUTOMATED EVALUATION OF BIOMARKER-STAINED SLIDES; 09/24/2018-09/23/2023
Sep 12, 20180$500.0KHHSN261201500003I; HHSN26100070; 400.020.0070.0001; NCI-DCEG; APPROPRIATED; AUTOMATED EVALUATION OF BIOMARKER-STAINED SLIDES; 09/24/2018-09/23/2023

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.